Toronto Dominion Bank
URGN icon

Toronto Dominion Bank’s UroGen Pharma URGN Stock Holding History

Toronto Dominion Bank’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,616,714
Closed -$47M – 2479
2026
Q1 		$47M Buy
+2,616,714
New +$52.5M 0.07% 249
2025
Q4 		– Sell
-3,190,510
Closed -$63.7M – 2289
2025
Q3 		$63.7M Hold
3,190,510
– – 0.1% 193
2025
Q2 		$43.7M Buy
3,190,510
+1,441,368
+82% +$13.8M 0.07% 226
2025
Q1 		$19.3M Hold
1,749,142
– – 0.04% 334
2024
Q4 		$18.6M Buy
+1,749,142
New +$20.9M 0.03% 360
2024
Q3 		– Sell
-6
Closed -$101 – 1442
2024
Q2 		$101 Hold
6
– – ﹤0.01% 1353
2024
Q1 		$90 Hold
6
– – ﹤0.01% 1339
2023
Q4 		$90 Hold
6
– – ﹤0.01% 1470
2023
Q3 		$84 Buy
+6
New +$96 ﹤0.01% 1694

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Toronto Dominion Bank's URGN Position: Q2 2026 in Review

Toronto Dominion Bank sold out of UroGen Pharma (URGN) in Q2 2026, closing a stake of 2,616,714 shares — an estimated $47M sold.

Toronto Dominion Bank first reported a position in URGN in Q3 2023 and held it in 9 quarters. The position peaked at $63.7M in Q3 2025. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Toronto Dominion Bank reported no remaining UroGen Pharma position as of Q2 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 2,616,714 UroGen Pharma shares in Q2 2026, an estimated $47M.
  • Toronto Dominion Bank first reported a position in UroGen Pharma in Q3 2023 and held it in 9 quarters.
  • Toronto Dominion Bank's UroGen Pharma position peaked at $63.7M in Q3 2025.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.